Stay updated on Durvalumab and Tremelimumab in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Durvalumab and Tremelimumab in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Durvalumab and Tremelimumab in NSCLC Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    A new history entry was added on 2026-05-12 (Version 53) with Revision: v3.5.4. It includes a Study Status update in the Study Record Versions.
    Difference
    0.3%
    Check dated 2026-05-15T04:17:41.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    Revision label updated from v3.5.2 to v3.5.3, indicating a new version of the page's revision history. This reflects an update to the page's metadata without altering the underlying study data or functionality.
    Difference
    0.1%
    Check dated 2026-04-30T17:55:24.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    Revision history updated: added v3.5.2 and removed v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-16T10:49:18.000Z thumbnail image
  6. Check
    68 days ago
    Change Detected
    Summary
    Revision history shows an addition of v3.5.0 and a deletion of v3.4.3. These entries document the version updates for the page.
    Difference
    0.1%
    Check dated 2026-03-18T16:45:29.000Z thumbnail image
  7. Check
    75 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.2 to v3.4.3. No user-facing content or functionality changes are introduced.
    Difference
    0.1%
    Check dated 2026-03-11T14:46:31.000Z thumbnail image
  8. Check
    82 days ago
    Change Detected
    Summary
    Latest history entry adds Contacts/Locations and Study Status to the study record. A deletion was recorded on 2025-09-16.
    Difference
    0.3%
    Check dated 2026-03-04T11:36:39.000Z thumbnail image

Stay in the know with updates to Durvalumab and Tremelimumab in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Durvalumab and Tremelimumab in NSCLC Clinical Trial page.